Drug discovery and design /

Strategies to reduce medical uncertainty and build evidence have become critical to the advancement of medical knowledge and modern medical practice. As new techniques and strategies have arisen, so has the need for a current reference work. Drug Discovery and Design examines the latest research in...

Full description

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Scolnick, Edward M.
Format: eBook
Language:English
Published: San Diego, Calif. ; London : Academic, ©2001.
Series:Advances in protein chemistry ; v. 56.
Subjects:
Online Access:Connect to the full text of this electronic book

MARC

Tag First Indicator Second Indicator Subfields
LEADER 00000cam a2200000 a 4500
001 in00005733821
005 20260326152630.0
006 m o d
007 cr cnu---unuuu
008 070904s2001 cauaf ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d OCLCQ  |d YDXCP  |d OCLCQ  |d YUM  |d IDEBK  |d E7B  |d OCLCQ  |d MERUC  |d OPELS  |d OCLCQ  |d OPELS  |d OCLCQ  |d DEBSZ  |d UAB  |d OCLCQ  |d OCLCF  |d OCLCO  |d D6H  |d OCLCO  |d CHVBK  |d OCLCO  |d OCLCA  |d OCLCQ  |d LEAUB  |d OCLCO  |d OCLCA  |d S2H  |d OCLCO  |d OCLCQ  |d OCLCO  |d COM  |d OCLCQ  |d OCLCO  |d OCLCL  |d OCLCQ  |d OCLCL 
019 |a 63020266  |a 648270227  |a 742283793  |a 814451413  |a 823106925  |a 823827157  |a 823896624  |a 824088713  |a 824135097  |a 906142861 
020 |a 9780080493381  |q (electronic bk.) 
020 |a 0080493386  |q (electronic bk.) 
020 |a 0120342561  |q (electronic bk.) 
020 |a 9780120342563  |q (electronic bk.) 
020 |a 1281010650 
020 |a 9781281010650 
035 |a (OCoLC)166885237  |z (OCoLC)63020266  |z (OCoLC)648270227  |z (OCoLC)742283793  |z (OCoLC)814451413  |z (OCoLC)823106925  |z (OCoLC)823827157  |z (OCoLC)823896624  |z (OCoLC)824088713  |z (OCoLC)824135097  |z (OCoLC)906142861 
050 4 |a QD431  |b .A3eb vol. 56 
072 7 |a MED  |x 023000  |2 bisacsh 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a MED  |x 072000  |2 bisacsh 
072 7 |a MED  |x 058170  |2 bisacsh 
072 7 |a PSD  |2 bicssc 
082 0 4 |a 615.19  |2 22 
049 |a TXAM 
245 0 0 |a Drug discovery and design /  |c edited by Edward M. Scolnick. 
260 |a San Diego, Calif. ;  |a London :  |b Academic,  |c ©2001. 
300 |a 1 online resource (xi, 567 pages, 4 unnumbered pages of plates) :  |b illustrations (some color) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Advances in protein chemistry ;  |v v. 56 
505 0 |a "Natural history" clinical trials : an enduring contribution to modern medical practice / Edward M. Scolnick, Eve E. Slater, George W. Williams -- Angiotensin-converting enzyme inhibitors / Joel Menard, Arthur Patchett -- HMG-CoA reductase inhibitors / Roger Illingworth, Jonathan A. Tolbert -- Cyclooxygenase-2 inhibitors / Alan S. Nies -- 5[alpha]-reductase inhibitors / John D. McConnell, Elizabeth Stoner -- Peroxisome proliferator-activated receptor (PPAR)[gamma] agonists for diabetes / David E. Moller, Douglas A. Greene -- Discovery and clinical development of HIV-1 protease inhibitors / Joel Huff, James Kahn -- Calcineurin inhibitors and the generalization of the presenting protein strategy / Kurt W. Vogel [and others] -- Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities / Fernand Labire [and others] -- Monoclonal antibody therapy / John W. Park, Josef Smolen -- Glucan synthase inhibitors as intifungal agents / Myra B. Kurtz, John H. Rex. 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
520 |a Strategies to reduce medical uncertainty and build evidence have become critical to the advancement of medical knowledge and modern medical practice. As new techniques and strategies have arisen, so has the need for a current reference work. Drug Discovery and Design examines the latest research in the development of these new strategies. Some of the topics covered include angiotensin converting enzyme inhibitors, HIV protease inhibitors, PPAR agonists for diabetes, and glucan synthase antifungal agents. 
650 0 |a Drugs  |x Design. 
650 0 |a Drug development  |x Methodology. 
650 2 |a Drug Design 
650 2 |a Drug Evaluation 
650 6 |a Médicaments  |x Conception. 
650 6 |a Médicaments  |x Développement  |x Méthodologie. 
650 7 |a MEDICAL  |x Drug Guides.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacy.  |2 bisacsh 
650 7 |a MEDICAL  |x Nursing  |x Pharmacology.  |2 bisacsh 
650 7 |a Drugs  |x Design  |2 fast 
650 1 7 |a Eiwitten.  |2 gtt 
650 1 7 |a Geneesmiddelen.  |2 gtt 
650 1 7 |a Enzymen.  |2 gtt 
655 7 |a Electronic books.  |2 local 
700 1 |a Scolnick, Edward M. 
710 2 |a ScienceDirect (Online service) 
776 0 8 |i Print version:  |t Drug discovery and design.  |d San Diego, Calif. ; London : Academic, ©2001  |z 0120342561  |z 9780120342563  |w (OCoLC)46393289 
830 0 |a Advances in protein chemistry ;  |v v. 56. 
856 4 0 |u http://proxy.library.tamu.edu/login?url=https://www.sciencedirect.com/science/bookseries/00653233/56  |z Connect to the full text of this electronic book  |t 0 
955 |a Elsevier ScienceDirect 2026-2027 
994 |a 92  |b TXA 
999 f f |i 16099a29-3fe3-4e33-b58a-b9a1eb8a3354  |s c1f7b2fe-fa1a-488f-a56b-9548556b4aa4  |t 0 
952 f f |a Texas A&M University  |b College Station  |c Electronic Resources  |s www_evans  |d Available Online  |t 0  |e QD431 .A3eb vol. 56  |h Library of Congress classification 
998 f f |a QD431 .A3eb vol. 56  |t 0  |l Available Online